NPSP Insider Trading Activity and SEC Form 4 Filings
NPSP insider trading summary
No open-market insider purchases or sales of Nps Pharmaceuticals Inc (NPSP) have been reported on SEC Form 4 in the past 12 months.
Latest NPSP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 10, 2015 | Susan E Graf | VP, Corp Development & Strateg | Sell | $308K (6,711 @ $45.87) |
| Feb 5, 2015 | Joseph J Rogus | SVP, GTO & Supply Chain Mngmt | Sell | $1.5M (32,622 @ $45.90) |
| Dec 17, 2014 | Luke M Beshar | EVP & CFO | Sell | $1.8M (52,258 @ $35.00) |
| Dec 17, 2014 | Rachel R Selisker | Director | Sell | $128K (3,708 @ $34.59) |
| Dec 17, 2014 | Joseph J Rogus | SVP Gbl Tech Oper Sup Chn Mgt | Sell | $576K (16,467 @ $35.00) |
| Dec 8, 2014 | Rachel R Selisker | Director | Sell | $799K (23,157 @ $34.50) |
| Nov 28, 2014 | Rachel R Selisker | Director | Sell | $401K (11,635 @ $34.50) |
| Nov 17, 2014 | Luke M Beshar | EVP & CFO | Sell | $1.4M (47,442 @ $30.01) |
| Nov 17, 2014 | Joseph J Rogus | SVP, Gbl Technical Operations | Sell | $804K (26,782 @ $30.00) |
| Nov 11, 2014 | Rachel R Selisker | Director | Sell | $448K (15,188 @ $29.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.